Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

MET-097i

Obesity Weekly News

Obesity Weekly News - September 29th 2025

Obesity Update: Pfizer–Metsera Acquisition, Lilly’s $6.5B API Expansion, &…

Obesity Weekly News

Obesity Weekly News - September 23rd 2025

Obesity Update: ASC47 Combo Gains, Quintuple Agonist, Mazdutide Launch,…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Coverage
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Obesity Video Recap—November 11, 2025
Endocrinology Today—November 11, 2025
Obesity Today—November 11, 2025
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery

Tags

ACLF bioinformatics BridgeBio cancer cardiomyopathy cardiovascular risk factors Coronary and Structural Interventions corporate venture capital cutaneous T-cell lymphoma delivery technology Elranatamab Epithelial biology European Union EVOQ Fanconi anemia FcRn blocker FDA Clearance Fingolimod gene editing gene therapy approval geneventiv therapeutics Global Burden of Disease Hanmi HM17321 heart failure congestion hematology HLTH inflammatory bowel disease ISP-001 lunit mNSCLC non viral vectors partnerships personalized cancer vaccine pharma PSVT Redx Pharma Relmada Therapeutics research infrastructure respiratory infections roflumilast 0.05% Sema4 TERN-601 Terumo Welldoc WHO Foundation

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Obesity Video Recap—November 11, 2025
Endocrinology Today—November 11, 2025
Obesity Today—November 11, 2025
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery

TAGS

ACLF bioinformatics BridgeBio cancer cardiomyopathy cardiovascular risk factors Coronary and Structural Interventions corporate venture capital cutaneous T-cell lymphoma delivery technology Elranatamab Epithelial biology European Union EVOQ Fanconi anemia FcRn blocker FDA Clearance Fingolimod gene editing gene therapy approval geneventiv therapeutics Global Burden of Disease Hanmi HM17321 heart failure congestion hematology HLTH inflammatory bowel disease ISP-001 lunit mNSCLC non viral vectors partnerships personalized cancer vaccine pharma PSVT Redx Pharma Relmada Therapeutics research infrastructure respiratory infections roflumilast 0.05% Sema4 TERN-601 Terumo Welldoc WHO Foundation

Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy